As companies face growing pressure to disclose their environmental and social impacts, ESG reporting has become a core part of doing business. Standards bring consistency and credibility to these ...

In 2024, we published our third annual stakeholder report to share out our successes and challenges. The Director's Note is excerpted below. Read the full report I’m excited to share some FY ‘24 ...

GRI Bio, Inc. has received a recommendation from the Independent Data Monitoring Committee to continue its Phase 2a study of GRI-0621 for the treatment of idiopathic pulmonary fibrosis (IPF) following ...

In 2023, we published our third annual stakeholder report to share out our successes and challenges. The Director's Note is excerpted below. READ THE FULL REPORT Dear Friends, This is our third annual ...

Piloting Corporate Sustainability Reporting in LDCs: Impacts, Experiences, and Lessons Learnt: A GRI Report (2020) ...